Administration officials confirm what we've been telling you for weeks: There aren't many doses available of the J&J vaccine at the moment and there won't be for awhile. @rachelcohrs reports on the 3rd #Covid19 vaccine to go into use in the US. https://t.co/Rz9zTq9Xwd
Four former @US_FDA commissioners take the virtual stage at our March 12 event to share their insights on the future of the agency.
Be part of this conversation.
Save your spot here: https://t.co/iYZXyfICbW
“I had never been in a situation where I could not go into a room. Never,” recalled Thompson, a staff chaplain at UAB Hospital, laughing at her own astonishment. “I was like, ‘What? I’m the chaplain. I go everywhere. That’s my superpower.’” https://t.co/Y3MErp2aix
Opinion: Paul’s characterization of transgender health care for minors — a characterization unfortunately commonplace in political circles — is factually inaccurate, rhetorically dangerous, and medically unsound. https://t.co/SL1xiwZSa3
The Food and Drug Administration on Saturday issued an emergency authorization for a Covid-19 vaccine developed by Johnson & Johnson, the third vaccine to be cleared for use in the United States and the first that requires only one dose. https://t.co/RDyY5p1nzu
After the news of the emergency authorization of the Johnson and Johnson vaccine, we've revisited our comparison of the existing #COVID19 vaccines.
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson https://t.co/BhzfHQsesZ